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Abstract
Aims/hypothesis Genome-wide association studies (GWAS)
have discovered many risk variants for type 2 diabetes.
However, estimates of the contributions of risk variants to type
2 diabetes predisposition are often based on highly selected
case–control samples, and reliable estimates of population-
level effect sizes are missing, especially in non-European
populations.
Methods The individual and cumulative effects of 59
established type 2 diabetes risk loci were measured in a
population-based China Kadoorie Biobank (CKB) study of
93,000 Chinese adults, including >7,100 diabetes cases.
Results Association signals were directionally consistent be-
tween CKB and the original discovery GWAS: of 56 variants
passing quality control, 48 showed the same direction of effect
(binomial test, p=2.3×10−8). We observed a consistent overall
trend towards lower risk variant effect sizes in CKB than in
case–control samples of GWAS meta-analyses (mean 19–22%
decrease in log odds, p≤0.0048), likely to reflect correction of
both ‘winner’s curse’ and spectrum bias effects. The associa-
tion with risk of diabetes of a genetic risk score, based on lead
variants at 25 loci considered to act through beta cell function,
demonstrated significant interactions with several measures of
adiposity (BMI, waist circumference [WC],WHR and percent-
age body fat [PBF]; all pinteraction < 1×10
−4), with a greater
effect being observed in leaner adults.
Conclusions/interpretation Our study provides further evi-
dence of shared genetic architecture for type 2 diabetes
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between Europeans and East Asians. It also indicates that even
very large GWAS meta-analyses may be vulnerable to sub-
stantial inflation of effect size estimates, compared with those
observed in large-scale population-based cohort studies.
Access to research materials Details of how to access China
Kadoorie Biobank data and details of the data release schedule
are available from www.ckbiobank.org/site/Data+Access.
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AGEN-T2D Asian Genetic EpidemiologyNetwork-
Type 2 Diabetes Consortium
CKB China Kadoorie Biobank
GRS Genetic risk score
GRS-BC Beta cell function related genetic risk
score
GRS-IR Insulin resistance related genetic risk
score
GRS-T Overall genetic risk score
GWAS Genome-wide association studies
HOMA-B HOMA of beta cell function
IR Insulin resistance
LD Linkage disequilibrium
MAF Minor allele frequency
PBF Percentage body fat
QC Quality control
ROC Receiver operating characteristic
SNP Single nucleotide polymorphism
TransEthnic Trans-ethnic type 2 diabetes GWAS
meta-analysis
TransEthnic + CKB Combined meta-analysis of the CKB
and trans-ethnic GWAS studies
WC Waist circumference
Introduction
Type 2 diabetes affects ~400 million people globally [1]. The
prevalence of type 2 diabetes has increased substantially in
Asian populations, and in China it is estimated that 100 mil-
lion adults (~11% of the adult population) are affected [2].
Lifestyle factors (e.g. physical inactivity), nutrition transitions
and increased adiposity are the chief determinants of type 2
diabetes, but genetic factors also play an important role.
Genome-wide association studies (GWAS) and large-scale
genotyping studies (e.g. MetaboChip and ExomeChip
genotyping arrays) have identified more than 90 type 2 diabe-
tes associated risk loci [3–28]. GWAS and replication studies
conducted in a range of ancestry groups have revealed that
most common-variant susceptibility loci are shared across eth-
nic groups [24, 29, 30]. While many type 2 diabetes suscepti-
bility variants identified in Europeans have been successfully
replicated in East Asians, failure to replicate (e.g. at ADCY5,
NOTCH2 and PRC1) likely arises from poor coverage by
genotyping arrays, ethnic differences in allele frequency, vari-
able linkage disequilibrium (LD) and limited statistical power.
As the number of type 2 diabetes associated variants has
increased, so has the value in including genetic data in models
to predict type 2 diabetes risk, weighting individual genetic
variants according to their reported effect size [31]. However,
effect estimates obtained from GWAS using case–control
studies are often inflated due to spectrum bias and/or ‘win-
ner’s curse’ [32, 33]. Spectrum bias describes the overestima-
tion of test performance that can arise from studying ‘clear-
cut’ cases or extremes of the underlying distribution (so-called
‘extreme phenotypes’) [32]. ‘Winner’s curse’ refers to the up-
ward bias in the estimated effect of a newly identified variant,
particularly when there is limited power to detect the true
association [33]. To avoid these biases, large-scale popula-
tion-based studies are required to obtain robust population-
specific estimates of both individual and joint effects of
GWAS-identified variants. The availability of such data re-
mains limited, especially in non-European populations, and
this motivated us to obtain population-based estimates of ef-
fect size in the China Kadoorie Biobank (CKB) study.
In addition, we constructed genetic risk scores (GRSs) to
investigate the separate genetic effects on diabetes of SNPs
that have been associated with beta cell dysfunction or insulin
resistance (IR). The association between certain genetic vari-
ants and type 2 diabetes risk has been reported to vary accord-
ing to obesity status [34], which could impact on the utility of
predictive models. Therefore, we assessed whether associa-
tions of these GRSs with diabetes were modified in individ-
uals with different degrees of adiposity.
Methods
Study population The study sample consisted of 93,131 in-
dividuals with genotype data, randomly selected from the
CKB study (www.ckbiobank.org), a prospective cohort of
512,891 Chinese adults. Details of the study design,
protocol, procedures and characteristics of CKB have been
described elsewhere [35]. Briefly, the baseline survey took
place from June 2004 to July 2008 in ten geographically
defined areas (5 urban, 5 rural) across China. In each study
area, permanent residents were identified through official
residential records, and invited to participate in the study. All
participants are prospectively followed up for cause-specific
mortality, morbidity and hospitalisation, using China CDC’s
Disease Surveillance Points and linkages to the national health
insurance claim databases [35]. Information about socio-
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demographic, lifestyle, medical history and current medica-
tion were collected by laptop-based questionnaires. Physical
measurements were recorded including height, weight, waist
and hip circumferences, and bio-impedance (Tanita BC-
418MA, Tokyo, Japan). Except in one study area, where the
protocol included fasting by all participants, initial screening
for hyperglycaemia involved immediate on-site testing of
non-fasting blood glucose using the SureStep Plus meter
(LifeScan, Milpitas, CA, USA). Participants with non-
fasting glucose levels ≥7.8 and <11.1 mmol/l were invited to
return for a fasting blood glucose test the next day.
Diabetes was defined either as a self-report of physician
diagnosis of diabetes or screen-detected diabetes, as previous-
ly reported [36]. For self-reported diabetes, those with an on-
set under age 30 and currently treated with insulin were con-
sidered as type 1 diabetes, and were excluded from the present
analyses. Screen-detected diabetes was defined as no prior
history of diabetes with a blood glucose level meeting any
one of the following criteria, if applicable: (1) a random blood
glucose level ≥7.0 mmol/l and a fasting time >8 h; (2) a ran-
dom blood glucose level ≥11.1mmol/l and a fasting time <8 h;
(3) a fasting blood glucose level ≥7.0 mmol/l. For the current
analysis, follow-up data were collected up to 31 December
2013 (Snapshot Database Release 9, April 2015). We com-
bined all cases of prevalent (5,483) and incident (1,626) dia-
betes to give a total of 7,109 cases and 86,022 non-diabetes
controls. All participants provided written informed consent
for follow-up and long-term storage of biological samples.
GenotypingA panel of 384 single nucleotide polymorphisms
(SNPs), selected on the basis of prior association with cardio-
vascular disease, risk factors and related phenotypes, were
genotyped in 95,680 randomly selected individuals from
CKB on the Illumina Golden Gate platform at the BGI labo-
ratory in Shenzhen, China. A total of 93,131 individuals aged
30–79 years passed quality control criteria (call rate ≥98%, no
sex mismatch, heterozygosity F statistic SD score <5). SNPs
with low call rate (<95%) or Hardy–Weinberg disequilibrium
(p<0.05/384=1.3×10−4) were excluded. Mean genotyping
concordance was 99.98% (range 98.66–100%) based on
2,063 duplicate samples included for quality control (QC)
purposes. The SNP panel included 59 GWAS-identified type
2 diabetes risk variants reported by October 2012, of which
five were originally reported in South Asians, 15 in East
Asians and 36 in Europeans. These lead SNPs were selected
based on the available association data from East Asian pop-
ulations and/or fine-mapping data in Europeans at the time of
array design and manufacturing. SinceHNF1A rs12427353 is
monomorphic in East Asians and genotyping of two variants
(PEPD rs3786897,KCNK16 rs3734618) failed QC, data were
available for 56 variants (Fig. 1). The majority of SNPs were
successfully genotyped in all selected samples except for four
(WFS1 rs10010131,DGKB rs2191349, RASGRP1 rs7403531
and GRK5 rs10886471), which were genotyped only in
batches comprising subsets of the cohort (49%, 80%, 90%
and 90% of participants, respectively). Estimates of related-
ness based on 235 independent SNPs, using the R package
SNPRelate [37], identified that 19% of participants had at
least one first-degree relative among those genotyped. We
present the results for the full dataset, but exclusion of
10,654 participants to eliminate first-degree relationships had
no appreciable effect on individual results or our overall con-
clusions. Genomic inflation was estimated atλ1000=1.06–1.08,
based on associations for 235 independent SNPs.
GRSs The risk variants at DUSP8/INS, DUSP9 and WFS1
were not included in GRS calculations because of parent-of-
origin-specific effects, location on the X-chromosome and
low genotyping rate, respectively. RBMS1 rs7593730 was also
excluded as it was associated with type 2 diabetes only in
Europeans. The remaining 52 variants were selected for the
overall GRS (GRS-T) (Fig. 1 and Electronic Supplementary
Material [ESM] Tables 1, 2). Five types of weighted GRS
(using weights derived from the natural logarithm of the per-
allele OR) were calculated, using data from: (1) DIAGRAMv3
GWAS meta-analysis (DIAGRAMv3) [15]; (2) GWAS meta-
analysis in East Asians (Asian Genetic Epidemiology
Network-Type 2 Diabetes Consortium [AGEN-T2D]) [14];
(3) DIAGRAM Metabochip meta-analysis (Metabochip) [15];
(4) a trans-ethnic type 2 diabetes GWAS meta-analysis
(TransEthnic) [24]; and (5) a combined meta-analysis of the
59 GWAS-identified T2D SNPs by October 2012
(93,131 Chinese adults from CKB study)
3 SNPs excluded:
Monomorphic: HNF1A rs7957197
Genotype failure: PEPD rs3786897
KCNK16 rs3734618
Single-locus variant analysis of 56 SNPs
• Associations with T2D in CKB
• Meta-analysis of CKB and AGEN-T2D study
• Comparison of effect sizes with Europeans
Genetic risk score analysis 
• GRS-T: 52 SNPs in total
• GRS-BC: 25 beta cell function related SNPs
• GRS-IR: 7 IR related SNPs
GRSs × adiposity interaction analysis






Unweighted/weighted by : 
DIAGRAM, AGEN-T2D, 
Metabochip, TransEthnic
Fig. 1 Flow chart of the analyses. T2D, type 2 diabetes
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CKB and trans-ethnic GWAS studies (TransEthnic + CKB)
(ESM Fig. 1).
Type 2 diabetes risk variants were classified, based on pre-
viously published data concerning their pathophysiological
mechanism, as being predominantly related to beta cell dys-
function, IR or neither (ESM Table 1). We updated the strat-
egy proposed by Vassy et al [38] by including more lines of
genetic and physiological evidence [15, 39–41]. Beta cell dys-
function related SNPs were identified by: (1) association with
decreased HOMAof beta cell function (HOMA-B; p<0.05,β
for HOMA-B<0 for risk allele) in non-diabetic individuals
[15]; (2) association with one of the beta cell function indices
during an OGTT (p<0.05, β<0 for risk allele) [40, 41]; (3)
presence in a locus influencing beta cell function according to
cluster analysis [40]; and/or (4) the existence of rare variants
responsible for forms of monogenic diabetes characterised by
insulin secretory failure (such as neonatal diabetes and
MODY). IR-related SNPs were identified by: (1) association
with increased HOMA-IR (p<0.05, β>0 for risk allele) in
non-diabetic individuals [41] or decreased insulin sensitivity
index (p<0.05, β<0 for risk allele) [15]; (2) association with
fasting insulin (p<0.05, β>0) [39]; (3) presence in a locus
influencing insulin sensitivity according to cluster analysis
[40]; (4) association with increased triacylglycerol or other
IR-related traits [39]; and (5) not acting primarily through
obesity (FTO rs9939609, MC4R rs12970134) [15]. Thus,
GRSs were constructed from 25 beta cell dysfunction related
SNPs (GRS-BC) and seven IR-related SNPs (GRS-IR) (ESM
Table 2). Missing genotypes were imputed by assigning the
mean genotype for that participant’s regional centre. To make
the weighted GRSs easier to interpret and more directly com-
parable to the unweighted score, values were rescaled as fol-
lows: GRS′=GRS× total number of the risk alleles/(2× sum
of weights). Each point of the rescaled GRS thus
corresponded to, on average, one additional risk allele.
Statistical analysisDeparture from Hardy–Weinberg equilib-
rium was assessed using a 1-df χ2 test. For the primary out-
come, logistic regression was used to estimate ORs and 95%
CIs of individual variants and GRSs for combined prevalent/
incident diabetes, adjusting for age, sex and regional centre.
Comparison of effect sizes (loge ORs) between CKB and pre-
vious studies was performed by inverse-variance weighted
least squares regression through the origin. To combine our
results with those from AGEN-T2D [14] or the TransEthnic
meta-analysis [24], fixed effects meta-analysis was performed
by inverse-variance weighting. We carefully checked the re-
gion of recruitment of the studies contributing to AGEN-T2D
and found no evidence of overlap with CKB. Floating abso-
lute risks were used to provide estimates of variance across
GRS quartiles [42]. BMI cut-point categories were defined
according to Asian criteria proposed by the WHO: normal
weight (BMI < 23 kg/m2); overweight (23 ≤BMI < 27.5
kg/m2); obese (BMI ≥27.5 kg/m2) [43]. Strata of waist cir-
cumference (WC), WHR and percentage body fat (PBF) were
defined by sex-specific tertiles. Tests for interaction between
adiposity and GRSs used logistic regression models including
GRS, adiposity variable of interest and GRS×variable inter-
action term, with additional adjustment for age, sex and re-
gional centre. Given that all SNPs were previously identified
at GWAS significance for type 2 diabetes in Europeans and/or
Asians, conventional Bonferroni correction would be overly
conservative; we used the Holm–Bonferroni method or per-
mutation procedures to control the family-wise error rate. For
completeness, we also present findings using a 5% false dis-
covery rate (Benjamini–Hochberg). In the meta-analyses,
Cochran’s Q test was used to assess between-study heteroge-
neity and Bonferroni correction was used to account for mul-
tiple testing (p<0.05/[55×3]=3.0×10−4). The discriminative
abilities of unweighted and weightedGRSs for risk of diabetes
were assessed by receiver operating characteristic (ROC)
curve analysis and compared using the DeLong test [44].
For 1000-fold cross-validation, weights were derived from a
repeated analysis excluding randomly selected sets of 0.1% of
the CKB sample, and using the resulting weights for the ex-
cluded individuals. The proportion of variance in phenotype
explained for each SNP or GRS was calculated according to
Shim et al [45] using previously reported means and SEs for
SNP effect sizes [15].We estimated power using ORs reported
in the original GWAS and sample size and risk allele frequen-
cies of our study with Quanto software (http://biostats.usc.
edu/Quanto.html) (ESM Table 3). We investigated regional
LD patterns among East Asians (CHB + JPT panel) and
Europeans (CEU panel) from HapMap release 27 using the
varLD algorithm [46], and presented results as Monte-Carlo
p values from 10,000 iterations. All reported p values are
nominal and 2-sided. Association analyses were performed
using R software version 3.0.2 (www.r-project.org).
Results
Participant characteristics Among the 93,131 CKB partici-
pants, there were 7,109 (7.6%) diabetes cases comprising
2,903 (3.1%) self-reported and 2,580 (2.8%) screen-detected
at baseline, and 1,626 (1.7%) incident cases of diabetes that
occurred during a mean (SD) of 7.1 (1.3) years follow-up
(Table 1). A total of 86,022 participants without diabetes were
considered controls. The overall mean BMI was 23.6 kg/m2.
Women had slightly higher BMI than men, and also had
higher prevalence and incidence of diabetes.
Association with individual variants in the CKB study
Table 2 shows the associations of 56 variants that passed QC
with diabetes risk, together with the corresponding values
from AGEN-T2D and a meta-analysis of CKB and AGEN-
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T2D. Risk allele frequencies observed in CKB were compa-
rable with those in the 1000 Genomes Project Phase 3 CHB +
CHS population. Sensitivity analysis showed that there was
no evidence of heterogeneity between regional centres in the
association of loci and risk of diabetes (ESM Tables 4-6). All
SNPs were common in CKB (minor allele frequency,
MAF > 0.05) except for variants at five loci: (NOTCH2
rs10923931 [MAF= 0.032]; THADA rs7578597 [0.007];
ADCY5 rs11708067 [0.003]; TCF7L2 rs7901695 [0.031];
and PRC1 rs8042680 [0.010]). Among the 56 variants, 48
had effects directionally consistent with those in the original
reports (binomial test, p=2.3×10−8) (ESM Tables 7, 8). Five
SNPs reached GWAS significance (p<5×10−8) and another
14 variants showed statistically significant association after
multiple-testing correction (Holm–Bonferroni, p<0.05); al-
ternatively, association was replicated for 30 SNPs at 5% false
discovery rate (Benjamini–Hochberg). All eight risk loci that
were identified in East Asian and Chinese Han GWAS
[14, 18] showed consistent effect directions. Among them,
MAEA and GLIS3 loci were significantly associated with
type 2 diabetes after correction for multiple testing.
Meta-analysis of CKB and AGEN-T2D studies Meta-
analysis combining the results of the present study with those
from AGEN-T2D [14], providing a total of 32,188 cases and
115,633 controls, further improved concordance of effect
estimates: after excluding variants identified in AGEN-T2D
or its contributing cohorts, 37 of 40 variants were directionally
consistent with European populations (binomial test
p=9.73×10−9). Ten variants identified in GWAS studies of
Europeans, plus nine variants reported in East Asian GWAS
studies, were genome-wide significant (Table 2, ESM
Tables 7, 8). With the exception of ZFAND3, we found no
heterogeneity for the associations at these loci across CKB
and AGEN-T2D (Table 2).
Consistency of effect sizes between East Asians and
Europeans Allelic ORs estimated in CKBwere highly correlat-
ed with those from Europeans (Fig. 2, r=0.81, p=2.1×10−36).
However, there was a clear trend towards lower effect sizes in
this population-based study of Chinese than in the predominantly
case–control samples of European descent included in GWAS
discovery studies, with amean proportional reduction in loge OR
of 19% (95% CI 6, 32; p=4.8×10−3). A very similar reduction
in effect size was observed when comparing CKB and AGEN-
T2D, which also comprised predominantly case–control cohorts
(22%; p=3.4×10−3, ESMFig. 2a). Effect sizeswere also strong-
ly correlated when comparing the meta-analysis of CKB and
AGEN-T2D with Europeans (r=0.85, p=7.6×10−37; propor-
tional reduction of 15%, p=0.026) (ESM Fig. 2b).
Heterogeneity in effect size was observed at RBMS1
rs7593730 and GCC1-PAX4 rs6467136 (p< 10–4) (ESM
Table 9), whose associations with diabetes were significant
only in Europeans and East Asians, respectively. This poten-
tially reflects the different LD patterns between East Asians
and Europeans at these loci (p < 0.0002 for both, ESM
Table 10). A further large difference in estimated effect size
between CKB (or AGEN-T2D + CKB) and Europeans, for
ADCY5 rs11708067 (OR [95% CI]: 1.92 [1.28, 2.88] vs 1.10
[1.06, 1.15]), likely reflects low power and uncertainty in ef-
fect size in CKB: neither the difference nor the diabetes asso-
ciation itself was significant after correction for multiple test-
ing. This SNP shows large differences in MAF (0.003 and
0.217 in Chinese and Europeans, respectively). In general,
however, risk allele frequencies were similar in CKB and
Europeans (CEU) (ESM Fig. 3, r=0.62, p=2.9×10−7).
GRSs and type 2 diabetes risk prediction ROC analysis to
assess prediction of diabetes in CKB by GRS-T based on 52
type 2 diabetes risk variants genotyped in the majority of
samples showed that, compared with the unweighted risk score
Table 1 Selected characteristics
at baseline among 93,131 geno-
typed participants in CKB
Variable Men Women All
Individuals, n (%) 37,677 (40.5) 55,454 (59.5) 93,131
Age, years 52.3 (10.8) 50.7 (10.5) 51.4 (10.7)
Random blood glucosea, mmol/l 6.0 (2.4) 6.2 (2.4) 6.1 (2.4)
WC, cm 82.0 (9.7) 79.1 (9.6) 80.3 (9.8)
Hip circumference, cm 90.6 (6.8) 91.1 (6.9) 90.9 (6.9)
BMI, kg/m2 23.4 (3.2) 23.8 (3.5) 23.6 (3.4)
WHR 0.90 (0.06) 0.87 (0.07) 0.88 (0.07)
PBF, % 21.9 (6.2) 32.1 (7.2) 28.1 (8.4)
Diabetes, n (%) 2,678 (7.1) 4,431 (8.0) 7,109 (7.6)
Clinically identified 1,101 (2.9) 1,802 (3.3) 2,903 (3.1)
Screen-detected 991 (2.6) 1,589 (2.9) 2,580 (2.8)
Incident 586 (1.6) 1,040 (1.9) 1,626 (1.8)
Data are means (SD) or n (%)
a Data only available for 92,166 participants (Men: 37,257; Women: 54,909)
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(C statistic [95% CI]: 0.574 [0.567, 0.580]), there were signif-
icant improvements in discrimination when using risk scores
based on weights from previous meta-analyses, TransEthnic in
particular (0.590 [0.583, 0.597], p=3.6×10−20, TransEthnic vs
unweighted). There was a further small but significant im-
provement in diabetes prediction byGRS-Tusingweights from
a meta-analysis including CKB (TransEthnic + CKB) (0.593
[0.586, 0.600]; p = 3.0 × 10−12, TransEthnic + CKB vs
TransEthnic) (Fig. 3 and ESM Table 11). Although somewhat
reduced, there remained an improvement following 1000-fold
cross-validation to minimise ‘over-fitting’ (0.591 [0.584,
0.598], p=1.8×10−3). Thus, in terms of diabetes prediction/
discrimination this TransEthnic + CKB meta-analysis (ESM
Tables 2, 11) provides the best-performing currently available
estimates of effect size for these type 2 diabetes associated
SNPs.
As expected, both unweighted and weighted GRS ro-
bustly associated with risk of diabetes (ESM Table 12).
Individuals in the highest quartile of GRS-T had an OR
of 2.34 (2.25, 2.45) compared with the lowest quartile.
Note that, for this and subsequent analyses, we present
the results of analyses employing TransEthnic-weighted
GRSs, which represent the best-performing external
weights—i.e. which avoid potential over-fitting and, there-
fore, do not require unnecessarily complex cross-validation
analyses. Conclusions were not materially affected by
using unweighted risk scores or other externally weighted
scores (ESM Table 12).
To investigate the genetic contribution to diabetes related to
beta cell dysfunction or IR, two separate GRSs (GRS-BC and
GRS-IR) were calculated based on 25 variants predominantly
associated with beta cell dysfunction and seven variants with
IR, respectively. Assessments of the proportion of variances in












































Fig. 2 Comparison estimates of
effect size (loge (OR)) between
Chinese and Europeans. The solid
line represents the line of equality,
and the result of regression is





























Fig. 3 ROC curves for type 2 diabetes GRS-Ts predicting type 2 diabetes
in CKB
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that they successfully targeted the phenotype of interest (ESM
Table 13). We identified associations of both GRS-BC and
GRS-IR with diabetes (ESM Table 12). The ORs for diabetes
were 2.17 (2.08, 2.26) and 1.19 (1.14, 1.25) when comparing the
extreme quartiles of TransEthnic-weighted GRS-BC and GRS-
IR, respectively (p for trend=4.82×10−111 and 1.68×10−7)
(ESM Fig. 4).
Effect modification by adiposity Stratified analyses were
performed to investigate the possible modifying effects
of adiposity on the associations of GRSs with diabetes.
Both GRS-T and GRS-BC showed significant interac-
tions with strata for each of BMI, WC, WHR and PBF
(pinteraction < 1 × 10
−4) (Table 3, ESM Table 15). In each
case, per unit GRS score effects were greater in partici-
pants who were leaner. We also observed a strong in-
verse association of GRS-BC with BMI, WC and PBF,
but not with WHR (ESM Table 15). In contrast, we
found no evidence of interaction between GRS-IR and
any of BMI, WC, WHR or PBF (pinteraction≥ 0.11).
Discussion
We tested associations of 56 variants with risk of diabetes in a
large-scale population-based study of Chinese adults. The ef-
fect sizes for the majority of diabetes loci were broadly similar
between Chinese and European populations. However, there
was an overall tendency towards lower effect sizes in our
unselected population, likely the consequence of reduced bias
(spectrum bias and ‘winner’s curse’). Similar reductions in
effect size were observed when comparing with previous data
from East Asians, so this is unlikely to be a reflection of
differences in patterns of LD.
Improved estimates of SNP effect sizes enabled construc-
tion of more accurate weighted GRS for disease prediction.
Although GRSs alone remain relatively poor predictors of
diabetes risk compared with traditional risk models, the in-
creasing numbers of associated SNPs nevertheless afford im-
provements for risk prediction [31]. Optimally, integration of
genotyping data into type 2 diabetes risk prediction models
requires reliable, unbiased, population-specific estimates of
the effect of risk variants. Most current effect size estimates
have been derived from gene discovery studies largely involv-
ing case–control samples and may suffer from ‘winner’s
curse’ and disease spectrum bias, the latter not being over-
come by ever-larger non-population-based cohort studies.
Re-estimation in population-based cohort studies of the effects
of GWAS-identified loci limits such biases [32, 33]. Thus, the
results from this study can be extrapolated to the Chinese
general population and used for inclusion of genetic data in
type 2 diabetes risk prediction models.
Previous studies have reported that the majority of com-
mon variants are shared across different ethnic groups [24, 30,
47, 48]. We have provided further evidence for shared genetic
architecture of type 2 diabetes between East Asian and
European populations. Further meta-analysis of CKB with
published data from AGEN-T2D improved our statistical
power to replicate associations originally reported in other
ancestries: the number of variants that achieved genome-
wide significance was increased from four to ten, and eight
additional SNPs showed significant association after multiple-
testing correction (ESM Tables 7, 8).
There are several potential reasons for failure to replicate
variants or inconsistencies of effect sizes. First, differences in
allele frequency between the original discovery population and
the replicating studies in other ethnic groups may affect power
for replication. Second, as effect sizes of more-recently identi-
fied type 2 diabetes loci become smaller (facilitated by ever-
larger sample sizes for discovery), a correspondingly larger
sample size is needed for replication. Thus, 19 out of the 26
SNPs with the largest effect sizes (OR≥1.08) but none of the
remainder reached genome-wide significance in the CKB-
AGEN-T2D meta-analysis. Third, differing patterns of LD
may mean that genotyped SNPs are less effective proxies for
the underlying causal variant in East Asians than in Europeans:
at most loci, the SNPs investigated in the present study were
identified in European studies. However, this is likely to apply
to only a small subset of loci since common-variant associa-
tions map to common haplotypes that are broadly shared be-
tween Europeans and East Asians [24, 30, 48]. Thus, at loci
where there was apparent non-concordance of effects (e.g.
RBMS1 rs7593730 and GCC1-PAX4 rs6467136), it remains
possible that the same causal variant is present in the two pop-
ulations and has similar effects. Fourth, these may represent
rare instances of ethnic differences in the occurrence of partic-
ular causal variants. This may be the case in Europeans for
GCC1-PAX4 rs6467136, for which locus there are no SNPs
with a type 2 diabetes association at even p<10−3 within
500 kb [15]. This may be elucidated by future fine-mapping
and sequencing studies [30].
We further investigated the genetic influence on disease
risk by stratifying on genetic variants related primarily to ei-
ther beta cell function or insulin sensitivity. While variants
identified in early GWAS are mainly implicated in beta cell
function, more recent studies have identified several variants
with a primary impact on IR [15, 40, 41]. Stratification of type
2 diabetes cases according to the separate contributions of
genetic effects on beta cell function and IR has the potential
to be informative for so-called ‘precision medicine’.
Consistent with previous reports [10, 34, 49], we identified
interactions of GRS with measures of adiposity: GRS-BC had
a larger effect size on diabetes among individuals with lower
BMI, WC, WHR or PBF. Since we observed a strong inverse
association of GRS-BC with BMI, WC and PBF (ESM
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Table 15), it remains possible that the observed interactions
with these measures of adiposity are an artefact of the dual
effects of GRS-BC on both diabetes risk and adiposity, for
instance due to ‘collider bias’ whereby analyses stratified by
a potential mediator can induce new relationships and intro-
duce confounding. However, this is not relevant for the inter-
action with WHR, which displayed a similar magnitude of
interaction despite not showing association with GRS-BC.
Therefore, we conclude that these observed effects of adipos-
ity of GRS-BC effect size are likely to be genuine. By con-
trast, we found no evidence for interactions between GRS-IR
and adiposity measures, which may reflect limited power
(owing to GRS-IR comprising one-third the number of
SNPs compared with GRS-BC and being less strongly as-
sociated with diabetes), but our findings are in line with
previous findings that IR scores are associated with inci-
dent type 2 diabetes independent of body size [50].
In conclusion, we report estimates, expected to be largely
free of ‘winner’s curse’ and spectrum bias, of the effect sizes
of diabetes risk variants in a general population cohort of
Chinese adults. We thereby identify the extent to which pre-
vious GWAS based on predominantly case–control studies are
affected by these biases. In addition to their utility for im-
provements in type 2 diabetes risk prediction, these more ac-
curate effect size estimates promise to be a powerful resource
for future Mendelian randomisation studies in Chinese
cohorts.
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